From Light Chain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from From Light Chain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In From Light Chain Today - Breaking & Trending Today

$Immix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023 - Vimarsana News$

Immix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023

Published: December 11, 2023

100% overall response rate and 70% complete response rate observed in standard of care relapsed/refractory AL Amyloidosis patients with median 6 lines of prior therapy in updated Phase...

Source: marketscreener.com

AstraZeneca advances scientific leadership in hematology at ASH 2023

Published: November 29, 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...

Source: marketscreener.com

$Immix Biopharma Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 9 Relapsed/Refractory AL Amyloidosis Patients - Vimarsana News$

Immix Biopharma Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 9 Relapsed/Refractory AL Amyloidosis Patients

Published: November 6, 2023

100% overall response rate observed in relapsed/refractory AL Amyloidosis patients with median 6 lines of prior therapyUpdated results will be communicated at the presentation time December 10,...

Source: marketscreener.com